Table 1.
Eyelid Reconstruction, Flaps, and Grafts
| Author | Year | Level of Evidence | Patients (n) | Mean Age (y) | Treatment Intervention/Modality | PG Percentage | Treatment to Resolve PG | Follow-up (mo) | |
|---|---|---|---|---|---|---|---|---|---|
| McNutt, et al57 | 2015 | III | 41 | 74 | Semicircular rotational flap closure | 10/41 | 24.4% | Topical steroids, triamcinolone injections, and excision | 9.8 |
| Galindo-Ferreiro, et al58 |
2018 | III | 62 | 34.2 | Dermis-fat graft in anophthalmic sockets | 8/62 | 12.9% | Not specified | 6 |
| Yamakawa, et al59 |
2022 | III | 11 | 85.7 | Transverse facial artery perforator flap | 1/11 | 9.0% | Not specified | 13 |
| Pham, et al60 | 2022 | III | 6 | 61.3 | One-stage free tarsoconjunctival graft and musculocutaneous transposition flap | 1/6 | 16.7% | Surgical excision | 8.5 |